Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03407534 · ClinicalTrials.gov registry record
Detection of Exocrine Pancreatic Insufficiency in Patients With Diarrhea and Bloating
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 142
- Enrollment target
NCT03407534 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 142 participants.
The verdict
NCT03407534 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 142 participants
- Enrollment target
Study Summary
The prevalence of exocrine pancreatic insufficiency (EPI) among patients presenting with diarrhea and bloating as their chief complaints is not well studied. Diarrhea and or bloating can be due to different etiologies such as celiac disease and irritable bowel syndrome. However, concomitant EPI can exacerbate these conditions, or be the main cause of the symptoms. Furthermore, some of these diagnoses can be epiphenomena or consequences of EPI. The Investigators hypothesize that EPI will be detected in significant proportion of patients with bloating or diarrhea and that early detection and management of EPI can prevent unnecessary work up for other causes of diarrhea.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2015-11 |
| Est. Completion | 2022-02-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03407534
The ClinicalTrials.gov registry entry for NCT03407534 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03407534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03407534 about?
NCT03407534 is a clinical study titled "Detection of Exocrine Pancreatic Insufficiency in Patients With Diarrhea and Bloating". The prevalence of exocrine pancreatic insufficiency (EPI) among patients presenting with diarrhea and bloating as their chief complaints is not well studied. Diarrhea and or bloating can be due to different etiologies such as celiac disease and irritable bowel syndrome. However, concomitant EPI can ...
What is the current status of trial NCT03407534?
This trial is currently completed. The enrollment target is 142 participants. The study started on 2015-11. Estimated completion is 2022-02-15.
Who is sponsoring clinical trial NCT03407534?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.